Fate Therapeutics's Earnings: A Preview


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


Fate Therapeutics (NASDAQ:FATE) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement.

Analysts estimate that Fate Therapeutics will report an earnings per share (EPS) of $-0.67.

Fate Therapeutics bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company beat EPS by $0.13, which was followed by a 2.97% increase in the share price the next day.

Here's a look at Fate Therapeutics's past performance and the resulting price change:

QuarterQ3 2021Q2 2021Q1 2021Q4 2020
EPS Estimate-0.58-0.53-0.43-0.39
EPS Actual-0.45-0.58-0.48-0.61
Price Change %2.97%11.44%-1.52%-9.45%

Stock Performance

Shares of Fate Therapeutics were trading at $33.95 as of February 24. Over the last 52-week period, shares are down 64.36%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

To track all upcoming earnings announcements, click here to use Benzinga Earnings Calendar.


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: EarningsBZI-EP